Biopharmadive.com - SEO Check

Übersicht der SEO Analyse
Metaangaben
80% 
Seitenqualität
83% 
Seitenstruktur
29% 
Verlinkung
51% 
Server
78% 
Externe Faktoren
100% 
SEO Score
Antwortzeit
0,87 s
Dateigröße
287,90 kB
Wörter
1855
Medien
111
Anzahl Links
138 Intern / 28 Extern

To-do Liste mit SEO Optimierungen

Meta-Angaben im HTML

Titel
(Extrem wichtig)
Biotech and Pharma Industry News | BioPharma Dive
Die Länge des Titels ist optimal. (477 Pixel von maximal 580 Pixel Länge)
Es gibt keine Wortwiederholungen im Titel.
Meta-Description
(Extrem wichtig)
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
Die Meta-Description ist zu lang. (1365 Pixel von maximal 1000 Pixel) Jetzt optimieren
Crawlbarkeit
(Extrem wichtig)
Es gibt keine Probleme beim Zugriff auf die Webseite.
Canonical Link
(Wichtig)
Es ist kein Canonical Link angegeben.
Sprache
(Wenig wichtig)
Im Text erkannte Sprache: en
Im HTML angegebene Sprache: en-us
Serverstandort: Kanada
Die Sprache wird im HTML Code wie folgt angegeben: en-us
Alternate/Hreflang Links
(Wenig wichtig)
Die Seite nutzt keine Alternate Links.
Weitere Metatags
(Wenig wichtig)
Es gibt keinen rel next Meta Tag auf der Seite.
Es gibt keinen rel prev Meta Tag auf der Seite.
Domain
(Wenig wichtig)
Die Domain ist keine Subdomain.
Die Länge der Domain ist gut.
Die Domain enthält keine Umlaute.
Seiten URL
(Wenig wichtig)
In der URL wurden keine Parameter entdeckt.
In der URL wurde keine Session ID entdeckt.
Die URL hat nicht zu viele Unterverzeichnisse.
Zeichensatzkodierung
(Wenig wichtig)
Die Angaben zur Zeichensatzkodierung (UTF-8) sind fehlerfrei.
Doctype
(Nice to have)
Die Doctype Angabe HTML 5 ist korrekt angegeben.
Die Doctype Angabe befindet sich an erster Stelle im HTML-Code.
Favicon
(Nice to have)
Das Favoriten Icon (Favicon) ist korrekt verlinkt.

Meta Tags

NameWert
viewportwidth=device-width, initial-scale=1.0
descriptionBioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
msapplication-TileImage/mstile-150x150.png?v=3
msapplication-TileColor#603cba
theme-color#ffffff
langen-us
fb:pages398644486955359
og:titleBiotech and Pharma Industry News | BioPharma Dive
og:descriptionBioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
og:imagehttps://d12v9rtnomnebu.cloudfront.net/divesite/header_image_logos/biopharma_dive_feed_header.jpg
x-ua-compatibleie=edge
charsetutf-8

Analysiere biopharmadive.com jetzt automatisch und vollständig mit allen Unterseiten!

Jetzt kostenlos testen
Garantiert keine Kosten während der Testphase.

Seitenqualität

Inhalt
(Extrem wichtig)
Wörter aus der H1 Überschrift werden nicht im Text der Seite verwendet.
Der Inhalt ist mit 1855 Wörtern in Ordnung.
Der Text besteht zu 27.4% aus Füllwörtern.
Worte aus dem Titel werden im Text wiederholt.
Im Text befindet sich eine Aufzählung, dies deutet auf eine gute Textstruktur hin.
Es wurden 29 Fließtextblöcke auf der Seite gefunden.
Es wurden keine Platzhalter Texte bzw. Bilder gefunden.
Es befinden sich keine Duplikate auf der Seite.
Die durchschnittliche Satzlänge ist mit 16.7 Wörtern gut.
Frames
(Extrem wichtig)
Die Seite hat kein Frameset.
Mobile
(Wenig wichtig)
Der angegebene Viewport (width=device-width, initial-scale=1.0) ist korrekt.
Mindestens ein Apple-Touch Icon ist definiert.
Bold- und Strongtags
(Wenig wichtig)
Die Nutzung von Strong- und Bold-Tags ist optimal. Wir empfehlen für diese Webseite die Verwendung von bis zu 37 Tags.
Bilder Optimierung
(Wenig wichtig)
Bei 5 Bildern fehlt das Alt-Attribut. Der Inhalt von Alt-Attributen wird von Suchmaschinen auch als Text gewertet und ist wichtig für die Bildersuche.
Soziale Vernetzung
(Nice to have)
Es befinden sich wenige Social-Sharing Möglichkeiten auf der Seite. Mit Plugins zum Teilen kann die Reichweite der Seite in sozialen Netzwerken erhöht werden.
Zusätzliches Markup
(Nice to have)
Es wurde kein zusätzliches Markup gefunden.
HTTPS
(Wenig wichtig)
Die Seite verwendet HTTPS um Daten sicher zu übertragen.
Alle eingebundenen Dateien werden ebenfalls über HTTPS ausgeliefert.

Medienliste

URLALT-AttributeTitel
...et/logo/publications/biopharma_black.svgBioPharma Dive
...et/logo/publications/biopharma_black.svgBioPharma Dive
...tic/img/menu_icons/menu.svg?273117231121menu
...c/img/menu_icons/search.svg?320116291121search
...ic/img/email_icons/mail.svg?273117231121Kein ALT-Attribut angegeben
...c/img/menu_icons/search.svg?320116291121search
...ic/img/menu_icons/close.svg?273117231121close search
...WdlL2RpdmVpbWFnZS9lbmhlcnR1LmpwZw==.webpEnhertu
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...WFnZS9NQV9oZWFkZXJfZVVpQk81cy5wbmc=.webpAn illustration for BioPharma Dive's deals database
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...W1hZ2VfMTA0MHg2MTZfa2NZMmh5Zy5wbmc=.webpA Young woman standing on the platform of a train station
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...WdlL2RpdmVpbWFnZS9OQTJfMTQ1Ni5qcGc=.webpPhysicians, researchers and healthcare professionals attend ASCO's annual Meeting on June 2, 2023 in Chicago.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMDI1ODM3NzM4LmpwZw==.webpA large group of dosing pens for subcutaneous injection of anti-obesity medication piled in a heap.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xNDgzOTIxNzkzLmpwZw==.webpA stack of newspapers are seen against a blue background.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xMjI3NzEwNDk4LmpwZw==.webpKein ALT-Attribut angegeben
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMjAyMTI1MjYzLmpwZw==.webpA person in a blue suit gestures while seated at a conference table.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xNzMyMDUyNTc5LmpwZw==.webpSpermatozoon is injected into an ovum with help of microneedle and holding pipette underneath a microscope
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xMjg4NjcwMjY5LmpwZw==.webpThe Moderna headquarters is seen on November 30, 2020 in Cambridge, Massachusetts.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMjA5Nzg3ODAxLmpwZw==.webpA sign spelling Roche hangs on the side of a building.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMjAzNjI4MTU5XzIuanBn.webpFDA administrator nominee Martin Makary speaks at a Senate confirmation hearing
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...W90ZWNoLWlwb3RyYWNrZXJoZWFkZXIucG5n.webpA stylized illustration of test tubes in front of a red line on a chart going up and to the right.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xNDgzOTIxNzkzLmpwZw==.webpA stack of newspapers are seen against a blue background.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...WFnZS9QZml6ZXJfSFFfRW50cmFuY2UuanBn.webpPfizer HQ entrance
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xOTc4MjM1MzE3LmpwZw==.webp23andMe
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...F9Hb3R0ZXNkaWVuZXJfakplSWV6Sy5qcGc=.webpA person in a white shirt sits in an office for a photograph.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...WFnZS9wYXRlbnRfdGhpY2tldF80LnBuZw==.webpA stylized illustration of a "patent thicket" for Jonathan Gardner's Nov. 1 story on Amgen's Enbrel.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...2RpdmVpbWFnZS9GREFfSFFfR2V0dHkuanBn.webpThe headquarters of the FDA, which has recently issued a recall for Teleflex air filters used in hospital respirators.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xMjM4ODMwMjMyLmpwZw==.webpA worker prepares ampoules of the Nuvaxovid vaccine against Covid-19 by Novavax in Berlin, Germany in February 2022.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xNDgzOTIxNzkzLmpwZw==.webpA stack of newspapers are seen against a blue background.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMTc0MjA0OTkxLmpwZw==.webpA person in a suit sits at a desk with a microphone.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xMjg5Nzg0NjQwLmpwZw==.webpA white office building bearing a sign for BioMarin Pharmaceutical stands against a blue sky.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...Wdlcy0xMjI3NzEwNDk4X3pJUnRuUlcuanBn.webpFDA
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...TY5MDc4MzcxMl8yYTc1ZmQ5M2MyX28uanBn.webpA photo of Sanofi headquarters in Paris, France.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...mJWaWVfVVNfSGVhZHF1YXJ0ZXJzLmpwZw==.webpAn AbbVie sign is seen on a building at the pharmaceutical company's U.S. headquarters.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMTk5NDI3NjE2LmpwZw==.webpSen. Chuck Grassley gestures as he speaks during a committee meeting.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...nts/buttons/right-arrow.svg?353714160519next icon
...XR0eUltYWdlcy0xOTc4MjM1MzE3LmpwZw==.webp23andMe
...XR0eUltYWdlcy0yMjAzNjI4MTU5XzIuanBn.webpFDA administrator nominee Martin Makary speaks at a Senate confirmation hearing
...F9Hb3R0ZXNkaWVuZXJfakplSWV6Sy5qcGc=.webpA person in a white shirt sits in an office for a photograph.
...2RpdmVpbWFnZS9GREFfSFFfR2V0dHkuanBn.webpThe headquarters of the FDA, which has recently issued a recall for Teleflex air filters used in hospital respirators.
...lib_icons/webinar-black.svg?141716111021studioID resource icon
...ib_icons/playbook-black.svg?141716111021studioID resource icon
...ib_icons/playbook-black.svg?141716111021studioID resource icon
...ars-focus-rare-disease-grows-2025-05-22/Kein ALT-Attribut angegeben
/static/img/offsite.svg?141716111021offsite link
...y/rfk-jr-maha-commission-report-5c13696dKein ALT-Attribut angegeben
/static/img/offsite.svg?141716111021offsite link
...-trump-medicaid-coverage-south-carolina/Kein ALT-Attribut angegeben
/static/img/offsite.svg?141716111021offsite link
/static/img/signup-dive.png?080016020822Daily Dive newsletter example
...oudfront.net/logo/corporate/ID_black.svgIndustry Dive Logo
...s/article_page/linkedin.svg?092716141024linkedin icon
...s/article_page/facebook.svg?440116200824facebook icon
...al_icons/article_page/x.svg?092716141024x icon
..._icons/article_page/rss.svg?440116200824rss feed icon
...ic/img/menu_icons/close.svg?273117231121close menu
...c/img/menu_icons/search.svg?320116291121search
...menu_icons/chevron_down.svg?410116200325down arrow

Seitenstruktur

H1 Überschrift
(Extrem wichtig)
Don't miss tomorrow's biopharma industry news
Zu viele H1 Überschriften
Überschriften
(Wichtig)
Es befinden sich 47 Überschriften auf der Seite. Die Anzahl der Überschriften sollte in einem besseren Verhältnis zum Text stehen.

Überschriftenstruktur

Überschriften HierarchieInhalt
H1 Don't miss tomorrow's biopharma industry news
H1 AI tool could help doctors ID breast cancers vulnerable to Enhertu
H2 Top stories
H2 The Latest
H3 FDA panel recommends keeping COVID shots targeted to same strain as last year
H3 Sanofi gains experimental Alzheimer’s drug through Vigil buyout
H3 A bespoke CRISPR therapy suggests a blueprint for treating ‘N-of-1’ diseases
H3 Women’s health faces growing headwinds, despite jump in venture investment
H3 Facing ‘uncertainty on steroids,’ biotech dealmakers tread more cautiously
H3 Biotech’s M&A outlook is uncertain. Track the deals that are happening here.
H3 From insight to impact: How eCOAs strengthen trial data quality
H3 Zepzelca, Tecentriq combo extends survival in hard-to-treat lung cancer
H3 Novo pressures GLP-1 compounders as FDA ban takes hold
H3 FDA advisers pan Pfizer’s PARP drug; Sarepta to resume Duchenne study
H3 FDA panel backs Darzalex for early stage multiple myeloma
H3 The Trump administration is remaking HHS. Track the changes here.
H3 Reproductive health startup raises $65M for infertility drugs
H3 Moderna pulls application for combo COVID, flu shot
H3 Roche strikes second Orionis deal to develop ‘molecular glues’ for cancer
H3 FDA sets stricter approval standards for COVID vaccines
H3 Biotech startups are built on venture capital. Track funding rounds here.
H3 Tourmaline shares fall on Phase 2 data; Schrödinger cuts staff
H3 Pfizer buys into PD-1/VEGF competition with 3SBio deal
H3 Regeneron wins bid to buy 23andMe out of bankruptcy
H3 Prime Medicine claims ‘proof of concept,’ but lays off staff in pivot
H3 Drug patents protect pharma profits. Track when they’ll expire.
H3 FDA OKs first blood test to aid Alzheimer’s diagnosis
H3 Novavax’s COVID vaccine gets FDA approval, but with limits
H3 Regeneron defeats Amgen in PCSK9 case; 2 cell therapy biotechs cut staff
H3 Novo CEO to depart as obesity drugmaker’s challenges rise
H3 BioMarin to buy rare disease drugmaker Inozyme for $270M
H3 FDA delays approval decision for Biohaven rare disease drug
H3 Sanofi to pour more than $20B into US drug research and manufacturing
H3 AbbVie stakes $335M on a startup’s RNAi drugs
H3 Stopping a ‘moral obscenity’: Senate Judiciary Committee expresses support for PBM reform
H3 Get the free newsletter
H3 Most Popular
H3 Library resources
H3 Company Announcements
H3 What We're Reading
H3 Events
H3 Industry Intel
H3 BioPharma Dive news delivered to your inbox
H3 Get BioPharma Dive in your inbox
H4 Explore
H4 Reach our audience
H4 Related Publications
Die internen Links haben teilweise dynamische Parameter. Alle internen URLs, welche nicht als nofollow markiert sind, sollten keine dynamischen Parameter aufweisen.
Einige der Linktexte wiederholen sich.
1 Links haben keinen Linktext oder nur Inhalt in Alt- und Titelattributen.
Die Anzahl an internen Links ist ok.
Keiner der Linktexte ist zu lang.
Es befinden sich zu viele externe Links (28) auf der Seite.
LinkAttributeLinktext
https://www.biopharmadive.com/Anchor Skip to main content
https://www.techtarget.com/ter...Neues Fenster Extern Subdomain Terms of Use
https://www.techtarget.com/pri...Neues Fenster Extern Subdomain Privacy Policy
https://www.biopharmadive.com/IMG-ALT BioPharma Dive
/deep-dive/Deep Dive
/library/Library
/events/Events
/press-release/Press Releases
/signup/?signup_location=headerNofollow Sign up
/signup/?signup_location=headerNofollow Textduplikat Sign up
/topic/pharma/Pharma
/topic/biotech/Biotech
/topic/fda/FDA
/topic/clinical-trials/Clinical Trials
/topic/deals/Deals
/topic/drug-pricing/Drug Pricing
/topic/gene-therapy/Gene Therapy
/news/her2-breast-cancer-diagn...IMG-ALT Enhertu
/news/her2-breast-cancer-diagn...AI tool could help doctors ID breast cancers vulnerable to Enhertu
/news/her2-breast-cancer-diagn...Read more ➔
/news/fda-covid-vaccine-advise...FDA panel recommends keeping COVID shots targeted to same strain as last year
/news/sanofi-vigil-acquisition...Sanofi gains experimental Alzheimer’s drug through Vigil buyout
/news/crispr-n-of-1-gene-editi...A bespoke CRISPR therapy suggests a blueprint for treating ‘N-of-1’ diseases
/news/womens-health-venture-fu...Women’s health faces growing headwinds, despite jump in venture investment
/news/deals-pharma-biotech-mar...Facing ‘uncertainty on steroids,’ biotech dealmakers tread more cautiously
/news/biotech-pharma-deals-mer...IMG-ALT An illustration for BioPharma Dive's deals database
/news/biotech-pharma-deals-mer...Biotech’s M&A outlook is uncertain. Track the deals that are happening here.
/topic/deals/Textduplikat Deals
/spons/from-insight-to-impact-...IMG-ALT A Young woman standing on the platform of a train station
/spons/from-insight-to-impact-...From insight to impact: How eCOAs strengthen trial data quality
/topic/clinical-trials/Textduplikat Clinical Trials
/news/zepzelca-tecentriq-small...IMG-ALT Physicians, researchers and healthcare professionals attend ASCO's annual Meeting on June 2, 2023 in Chicago.
/news/zepzelca-tecentriq-small...Zepzelca, Tecentriq combo extends survival in hard-to-treat lung cancer
/topic/pharma/Textduplikat Pharma
/news/novo-access-wegovy-glp-1...IMG-ALT A large group of dosing pens for subcutaneous injection of anti-obesity medication piled in a heap.
/news/novo-access-wegovy-glp-1...Novo pressures GLP-1 compounders as FDA ban takes hold
/topic/manufacturing/Manufacturing
/news/pfizer-talzenna-prostate...IMG-ALT A stack of newspapers are seen against a blue background.
/news/pfizer-talzenna-prostate...FDA advisers pan Pfizer’s PARP drug; Sarepta to resume Duchenne study
/topic/pharma/Textduplikat Pharma
/news/fda-panel-backs-darzalex...Kein Text
/news/fda-panel-backs-darzalex...FDA panel backs Darzalex for early stage multiple myeloma
/topic/pharma/Textduplikat Pharma
/news/hhs-fda-restructuring-la...IMG-ALT A person in a blue suit gestures while seated at a conference table.
/news/hhs-fda-restructuring-la...The Trump administration is remaking HHS. Track the changes here.
/topic/pharma/Textduplikat Pharma
/news/repronovo-series-a-ferti...IMG-ALT Spermatozoon is injected into an ovum with help of microneedle and holding pipette underneath a microscope
/news/repronovo-series-a-ferti...Reproductive health startup raises $65M for infertility drugs
/topic/biotech/Textduplikat Biotech
/news/moderna-withdraw-fda-cov...IMG-ALT The Moderna headquarters is seen on November 30, 2020 in Cambridge, Massachusetts.
/news/moderna-withdraw-fda-cov...Moderna pulls application for combo COVID, flu shot
/topic/biotech/Textduplikat Biotech
/news/roche-orionis-molecular-...IMG-ALT A sign spelling Roche hangs on the side of a building.
/news/roche-orionis-molecular-...Roche strikes second Orionis deal to develop ‘molecular glues’ for cancer
/topic/biotech/Textduplikat Biotech
/news/fda-covid-booster-approv...IMG-ALT FDA administrator nominee Martin Makary speaks at a Senate confirmation hearing
/news/fda-covid-booster-approv...FDA sets stricter approval standards for COVID vaccines
/topic/fda/Textduplikat FDA
/news/biotech-venture-capital-...IMG-ALT A stylized illustration of test tubes in front of a red line on a chart going up and to the right.
/news/biotech-venture-capital-...Biotech startups are built on venture capital. Track funding rounds here.
/topic/biotech/Textduplikat Biotech
/news/tourmaline-pacibekitug-s...Textduplikat IMG-ALT A stack of newspapers are seen against a blue background.
/news/tourmaline-pacibekitug-s...Tourmaline shares fall on Phase 2 data; Schrödinger cuts staff
/topic/pharma/Textduplikat Pharma
/news/pfizer-3sbio-pd1-vegf-ca...IMG-ALT Pfizer HQ entrance
/news/pfizer-3sbio-pd1-vegf-ca...Pfizer buys into PD-1/VEGF competition with 3SBio deal
/topic/pharma/Textduplikat Pharma
/news/regeneron-23andme-acquir...IMG-ALT 23andMe
/news/regeneron-23andme-acquir...Regeneron wins bid to buy 23andMe out of bankruptcy
/topic/biotech/Textduplikat Biotech
/news/prime-medicine-restructu...IMG-ALT A person in a white shirt sits in an office for a photograph.
/news/prime-medicine-restructu...Prime Medicine claims ‘proof of concept,’ but lays off staff in pivot
/topic/biotech/Textduplikat Biotech
/news/patent-cliff-pharmaceuti...IMG-ALT A stylized illustration of a "patent thicket" for Jonathan Gardner's Nov. 1 story on Amgen's Enbrel.
/news/patent-cliff-pharmaceuti...Drug patents protect pharma profits. Track when they’ll expire.
/topic/pharma/Textduplikat Pharma
/news/fda-blood-test-alzheimer...IMG-ALT The headquarters of the FDA, which has recently issued a recall for Teleflex air filters used in hospital respirators.
/news/fda-blood-test-alzheimer...FDA OKs first blood test to aid Alzheimer’s diagnosis
/topic/marketing/Marketing
/news/novavax-covid-vaccine-fd...IMG-ALT A worker prepares ampoules of the Nuvaxovid vaccine against Covid-19 by Novavax in Berlin, Germany in February 2022.
/news/novavax-covid-vaccine-fd...Novavax’s COVID vaccine gets FDA approval, but with limits
/topic/biotech/Textduplikat Biotech
/news/regeneron-amgen-pcsk9-tr...Textduplikat IMG-ALT A stack of newspapers are seen against a blue background.
/news/regeneron-amgen-pcsk9-tr...Regeneron defeats Amgen in PCSK9 case; 2 cell therapy biotechs cut staff
/topic/pharma/Textduplikat Pharma
/news/novo-nordisk-ceo-step-do...IMG-ALT A person in a suit sits at a desk with a microphone.
/news/novo-nordisk-ceo-step-do...Novo CEO to depart as obesity drugmaker’s challenges rise
/topic/pharma/Textduplikat Pharma
/news/biomarin-inozyme-acquisi...IMG-ALT A white office building bearing a sign for BioMarin Pharmaceutical stands against a blue sky.
/news/biomarin-inozyme-acquisi...BioMarin to buy rare disease drugmaker Inozyme for $270M
/topic/deals/Textduplikat Deals
/news/biohaven-fda-drug-approv...Textduplikat IMG-ALT FDA
/news/biohaven-fda-drug-approv...FDA delays approval decision for Biohaven rare disease drug
/topic/biotech/Textduplikat Biotech
/news/sanofi-11-billion-us-dru...IMG-ALT A photo of Sanofi headquarters in Paris, France.
/news/sanofi-11-billion-us-dru...Sanofi to pour more than $20B into US drug research and manufacturing
/topic/manufacturing/Textduplikat Manufacturing
/news/abbvie-adarx-rna-interfe...IMG-ALT An AbbVie sign is seen on a building at the pharmaceutical company's U.S. headquarters.
/news/abbvie-adarx-rna-interfe...AbbVie stakes $335M on a startup’s RNAi drugs
/topic/biotech/Textduplikat Biotech
/news/senate-judiciary-backs-p...IMG-ALT Sen. Chuck Grassley gestures as he speaks during a committee meeting.
/news/senate-judiciary-backs-p...Stopping a ‘moral obscenity’: Senate Judiciary Committee expresses support for PBM reform
/topic/pharma/Textduplikat Pharma
/?page=2More stories
IMG-ALT next icon
https://www.techtarget.com/ter...Neues Fenster Extern Subdomain Textduplikat Terms of Use
https://www.techtarget.com/pri...Neues Fenster Extern Subdomain Textduplikat Privacy Policy
/news/regeneron-23andme-acquir...Textduplikat IMG-ALT 23andMe
/news/regeneron-23andme-acquir...Textduplikat Regeneron wins bid to buy 23andMe out of bankruptcy
/news/fda-covid-booster-approv...Textduplikat IMG-ALT FDA administrator nominee Martin Makary speaks at a Senate confirmation hearing
/news/fda-covid-booster-approv...Textduplikat FDA sets stricter approval standards for COVID vaccines
/news/prime-medicine-restructu...Textduplikat IMG-ALT A person in a white shirt sits in an office for a photograph.
/news/prime-medicine-restructu...Textduplikat Prime Medicine claims ‘proof of concept,’ but lays off staff in pivot
/news/fda-blood-test-alzheimer...Textduplikat IMG-ALT The headquarters of the FDA, which has recently issued a recall for Teleflex air filters used in hospital respirators.
/news/fda-blood-test-alzheimer...Textduplikat FDA OKs first blood test to aid Alzheimer’s diagnosis
http://resources.industrydive....Neues Fenster Extern Subdomain Scaling Smarter: How a Modern Tech Stack Fuels Diagnostic Lab Growth
https://biopharmadive.tradepub...Neues Fenster Extern Subdomain Supporting Patient Safety Through Supply Chain Management
https://biopharmadive.tradepub...Neues Fenster Extern Subdomain How Each Step in a Clinical Trial Fuels the Next
/library/View all
/press-release/Textduplikat View all
/press-release/get-started/Post a press release
https://www.reuters.com/busine...Neues Fenster Extern Subdomain Prices for new US drugs doubled in 4 years as focus on rare disease grows
IMG-ALT offsite link
https://www.wsj.com/politics/p...Neues Fenster Extern Subdomain What’s Inside RFK Jr.’s MAHA Report
IMG-ALT offsite link
https://kffhealthnews.org/news...Neues Fenster Extern Trump Won’t Force Medicaid to Cover GLP-1s for Obesity. A Few States Are Doing It Anyway.
IMG-ALT offsite link
/what-we-are-readingTextduplikat View all
https://events.industrydive.co...Neues Fenster Extern Subdomain State of Oncology Research
/selfservice/event-listings/co...Promote an event
http://resources.industrydive....Neues Fenster Extern Subdomain Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance
http://resources.industrydive....Neues Fenster Extern Subdomain Unlock the Potential of Life Sciences and Health Systems Partnerships
https://resources.industrydive...Neues Fenster Extern Subdomain Top Ways that AI Will Change Life Sciences
https://www.techtarget.com/ter...Neues Fenster Extern Subdomain Textduplikat Terms of Use
https://www.techtarget.com/pri...Neues Fenster Extern Subdomain Textduplikat Privacy Policy
https://www.industrydive.com/Extern Subdomain IMG-ALT Industry Dive Logo
https://www.linkedin.com/compa...Extern Subdomain IMG-ALT linkedin icon
https://www.facebook.com/bioph...Extern Subdomain IMG-ALT facebook icon
https://twitter.com/BioPharmaDiveExtern IMG-ALT x icon
/feeds/news/Subdomain IMG-ALT rss feed icon
/about/About
/editors/Editorial Team
/contact/Contact Us
/signup/?signup_location=foote...Nofollow Newsletter
/selfservice/article-licensing...Nofollow Purchase Licensing Rights
/press-release/Textduplikat Press Releases
/what-we-are-reading/What We're Reading
/advertise/Advertising
/press-release/get-started/Textduplikat Post a press release
/selfservice/event-listings/co...Textduplikat Promote an event
https://www.healthcaredive.com/Extern Subdomain Healthcare Dive
https://www.medtechdive.com/Extern Subdomain MedTech Dive
https://www.industrydive.com/i...Extern Subdomain other publications
https://www.techtarget.com/pri...Extern Subdomain Privacy policy
https://www.techtarget.com/ter...Extern Subdomain Terms of use
https://www.industrydive.com/t...Extern Subdomain Take down policy
https://www.biopharmadive.com/Home
/topic/pharma/Textduplikat Pharma
/topic/biotech/Textduplikat Biotech
/topic/fda/Textduplikat FDA
/topic/clinical-trials/Textduplikat Clinical Trials
/topic/deals/Textduplikat Deals
/topic/drug-pricing/Textduplikat Drug Pricing
/topic/gene-therapy/Textduplikat Gene Therapy
/deep-dive/Textduplikat Deep Dive
/library/Textduplikat Library
/events/Textduplikat Events
/press-release/Textduplikat Press Releases
https://www.techtarget.com/ter...Neues Fenster Extern Subdomain Textduplikat Terms of Use
https://www.techtarget.com/pri...Neues Fenster Extern Subdomain Textduplikat Privacy Policy

Serverkonfiguration

HTTP-Weiterleitungen
(Extrem wichtig)
Die Seite leitet weiter auf "https://www.biopharmadive.com/"
HTTP-Header
(Wichtig)
Es wird kein X-Powered HTTP-Header mitgesendet.
Der Webserver überträgt die Webseite (HTML) komprimiert.
Performance
(Wenig wichtig)
Die Antwortzeit der HTML-Seite ist mit 0,87 Sekunden länger als die empfohlene Zeit von maximal 0,4 Sekunden. Eine hohe Antwortzeit verlängert unnötig das Crawling und sorgt für eine schlechte User Experience.
Die Dateigröße des HTML-Dokuments ist mit 288 kB in Ordnung.

HTTP-Header

NameWert
dateSun, 25 May 2025 09:24:08 GMT
content-typetext/html; charset=utf-8
sniply-optionsBLOCK
expiresSun, 25 May 2025 09:25:56 GMT
cache-controlmax-age=120
strict-transport-securitymax-age=31536000; includeSubDomains
x-locationEU
varyCookie, Accept-Encoding
x-varnish209497833 207478037
age11
via1.1 varnish (Varnish/7.1)
cf-cache-statusDYNAMIC
set-cookie283 Zeichen
servercloudflare
cf-ray9453fa5ebe686ee7-CDG
content-encodingbr
alt-svch3=":443"; ma=86400
statuscode200
http_versionHTTP/2

Externe Faktoren

Die Seite wird von Wikipedia verlinkt.
Die Seite ist exzellent von anderen Webseiten verlinkt.
Die Seite hat Backlinks von 213 verweisenden Domains.
Die Seite hat insgesamt 49.401 Backlinks.
Die Seite hat Backlinks von 187 verschiedenen IP Adressen.

Robots.txt

#
#                ..;coxkOOOOOOkxoc;'.
#             .:d0NWMMMMMMMMMMMMMMWN0xc'
#          .:kXMMMMMMMMMMMMMMMMMMMMMMMXl.
#        .c0WMMMMMMMMMMMMMMMMMMMMMMMXd'
#       ,OWMMMMMMMMMMMMMMMMMMMMMMMXo'       ..
#      cXMMMMMMXo::::::::::::::col.       .lKXl.
#     lNMMMMMMM0'                       .lKWMMNo
#    :XMMMMMMMM0'                     .l0WMMMMMNc
#   .OMMMMMMMMM0'     .ccccccc;.      ,KMMMMMMMMO.
#   :NMMMMMMMMM0'     oWMMMMMMWKc.     oWMMMMMMMN:
#   lWMMMMMMMMM0'     oWMMMMMMMMX:     ,KMMMMMMMMo
#   oMMMMMMMMMM0'     oWMMMMMMMMNc     ,KMMMMMMMMd
#   cNMMMMMMMMM0'     oWMMMMMMMNd.     lWMMMMMMMWl
#   '0MMMMMMMMWk.     ,oooooooc'      ,0MMMMMMMMK,
#    oWMMMMMMXo.                     ,0MMMMMMMMWo
#    .xWMMMXd'                     ,dXMMMMMMMMWk.
#     .xWNx'       .',''''''',,;coONMMMMMMMMMWk.
#      .:,       .l0WWWWWWWWWWWMMMMMMMMMMMMMNd.
#              .lKWMMMMMMMMMMMMMMMMMMMMMMMWk;
#            .lKWMMMMMMMMMMMMMMMMMMMMMMMNk;.
#            .ckXWMMMMMMMMMMMMMMMMMMWXkl'
#               .;ldO0XNWWWWWWNXKOxl;.
#                    ..'',,,,''..
#
#

# NOTE: Allow is a non-standard directive for robots.txt. It is allowed by Google bots. See https://developers.google.com/search/reference/robots_txt#allow

User-agent: *
# Crawl delay asks bots to wait this many seconds between requests. Ignored by google.
Crawl-delay: 5
Disallow: /admin/
Disallow: /newsletter/
Disallow: /healthcheck/
Disallow: /subpage/
Disallow: /ckeditor/
Disallow: /api/
Disallow: /static/images/
Disallow: /subscriber/
Disallow: /selfservice/
Disallow: /press-release/preview/
Disallow: /press-release/editor/

# no deep queries to search
Disallow: /search/*
Allow: /search/$

# don't index our dynamic images
Disallow: /user_media/
Disallow: /imgproxy/

# don't deep index topic pages
Disallow: /topic/?page=*

Allow: /sitemap.xml

#
# Rules for specific crawlers below. Note that these don't stack. If you create a specific user-agent rule
# you should copy the rules over from '*' above by hand.
#

# Allow Twitter to see all links
User-agent: Twitterbot
Crawl-delay: 5
Disallow:

# Allow Googlebot-News to see header images and favicons, BUT make it follow all the directives from our * group
# See below link for why we have to repeat these directives
# https://developers.google.com/search/reference/robots_txt#order-of-precedence-for-user-agents
User-agent: Googlebot-News
Disallow: /admin/
Disallow: /newsletter/
Disallow: /healthcheck/
Disallow: /subpage/
Disallow: /ckeditor/
Disallow: /api/
Disallow: /static/images/
Disallow: /subscriber/
Disallow: /selfservice/
Disallow: /press-release/preview/
Disallow: /press-release/editor/

# no deep queries to search
Disallow: /search/*
Allow: /search/$

Allow: /google_news_sitemap.xml
# Allow Google News to see header images and favicons
Allow: /user_media/
Allow: /imgproxy/
Allow: /static/images/favicons


# Googlebot-Image is now used for favicons. Allow it to see favicon-related files but nothing else
User-agent: Googlebot-Image
Disallow: /
Allow: /imgproxy/
Allow: /static/images/favicons
Allow: /favicon.ico
Allow: /white-favicon.ico
Allow: /apple-touch-icon.png
Allow: /favicon-32x32.png
Allow: /white-favicon-32x32.png
Allow: /favicon-16x16.png
Allow: /white-favicon-16x16.png
Allow: /site.webmanifest
Allow: /safari-pinned-tab.svg
Allow: /browserconfig.xml
Allow: /android-chrome-144x144.png
Allow: /mstile-150x150.png

# Don't let PetalBot crawl at all
User-agent: PetalBot
Disallow: /

# Block ChatGPT bot https://platform.openai.com/docs/gptbot
User-agent: GPTBot
Disallow: /

# Block sentione.com
User-agent: sentibot
Disallow: /

# block seoclarity.net/bot.html
User-agent: claritybot
Disallow: /

# block omgili.com/crawler.html
User-Agent: omgilibot
Disallow: /
User-Agent: omgili
Disallow: /

# All Facebook crawler user-agent to see all
User-agent: facebookexternalhit/1.1
Disallow:

User-agent: AhrefsBot
# We want this bot to crawl way slower https://ahrefs.com/robot/
Crawl-Delay: 30

Disallow: /admin/
Disallow: /newsletter/
Disallow: /healthcheck/
Disallow: /subpage/
Disallow: /ckeditor/
Disallow: /api/
Disallow: /static/images/
Disallow: /subscriber/
Disallow: /selfservice/
Disallow: /press-release/preview/
Disallow: /press-release/editor/

# no deep queries to search
Disallow: /search/*
Allow: /search/$

# don't index our dynamic images
Disallow: /user_media/
Disallow: /imgproxy/

Disallow: /topic/
Disallow: /editors/

User-agent: Amazonbot
# Restrict what Amazonbot (Alexa) can see, and a
Crawl-Delay: 10

Disallow: /admin/
Disallow: /newsletter/
Disallow: /healthcheck/
Disallow: /subpage/
Disallow: /ckeditor/
Disallow: /api/
Disallow: /static/images/
Disallow: /subscriber/
Disallow: /selfservice/
Disallow: /press-release/preview/
Disallow: /press-release/editor/

# no deep queries to search
Disallow: /search/*
Allow: /search/$

# don't index our dynamic images
Disallow: /user_media/
Disallow: /imgproxy/

Disallow: /topic/
Disallow: /editors/
Disallow: /signup/*
Allow: /signup/$

User-agent: amazon-QBusiness    # Amazon Q Web Crawler
Disallow: /

User-agent: amazon-kendra # Amazon Kendra Web Crawler
Disallow: /

Suchvorschau

www.biopharmadive.com
Biotech and Pharma Industry News | BioPharma Dive
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.

Wichtigste Suchbegriffe

Folgende Keywords wurden erkannt. Überprüfe die Optimierung dieser Keywords für Deine Seite.

KeywordErgebnisPrüfen
Pharma93%Check
biopharma92%Check
BioPharma Dive87%Check
news81%Check
Dive80%Check
Pharma Industry80%Check
Pharma Industry News80%Check
Biotech Pharma79%Check
Industry News74%Check
industry68%Check

Analysiere biopharmadive.com jetzt automatisch und vollständig mit allen Unterseiten!

Jetzt kostenlos testen
Garantiert keine Kosten während der Testphase.

Cookie Einstellungen

Wir verwenden Cookies, damit unsere Website funktioniert und auch für Analyse- und Werbezwecke. Du kannst optionale Cookies selbstverständlich auch deaktivieren, siehe die folgenden Links für weitere Informationen.

Diese Cookies werden für grundlegende Websitefunktionen benötigt.

Damit wir besser verstehen, wie Besucher unsere Website nutzen.

Damit wir für Dich passgenaue Angebote bereitstellen können.